Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 391 across all filing types
Latest filing 2024-02-08 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
주요사항보고서(제3자의전환사채매수선택권행사)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details the exercise of a call option (매수선택권) on convertible bonds by a third party. This type of regulatory disclosure regarding capital structure changes, specifically related to convertible securities and corporate financing, falls under the 'Regulatory Filings' category as it is a specific statutory disclosure requirement in the Korean market that does not fit into the other specialized categories like M&A or Share Issues.
2024-02-08 Korean
주요사항보고서(제3자의전환사채매수선택권행사)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission in South Korea. It specifically details the exercise of a call option (매수선택권) on convertible bonds by a third party (Global X Investment Association). This type of filing relates to capital structure changes and financial instruments, which falls under the 'Capital/Financing Update' category. It is not a report publication announcement, but rather the primary disclosure of a specific corporate financial event.
2024-02-08 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Medifron) regarding the adjustment of the conversion price of convertible preferred shares due to a decline in market price. This type of disclosure is a standard corporate action related to capital structure and financing instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate fit as it covers updates on financing activities and capital structure changes, including adjustments to convertible securities.
2024-01-02 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of shares, and the underlying methodology based on market price fluctuations. This type of filing is a standard corporate disclosure regarding capital structure changes and financing instruments, which falls under the 'Capital/Financing Update' category.
2024-01-02 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the closure of the shareholder register and the setting of a record date for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or voting results, but rather serves as a formal regulatory announcement of the procedural steps for the meeting. Given it is a standard regulatory notification that does not fit into specific categories like 'DVA' (results) or 'AGM-R' (presentation materials), it is classified as a general regulatory filing.
2023-12-15 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Adjustment of Conversion Price' (전환가액의 조정) for convertible bonds issued by Medifron. This type of filing details changes to the capital structure, specifically the conversion price of debt instruments due to market price fluctuations. According to the provided definitions, updates on capital structure changes and financing instruments fall under the 'Capital/Financing Update' (CAP) category.
2023-11-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.